Last reviewed · How we verify
Visipaque - Hydrocortancyl
Visipaque is a non-ionic, iso-osmolar contrast medium that enhances radiographic visualization of blood vessels and organs during diagnostic imaging procedures.
Visipaque is a non-ionic, iso-osmolar contrast medium that enhances radiographic visualization of blood vessels and organs during diagnostic imaging procedures. Used for Coronary angiography and ventriculography, Peripheral vascular angiography, Cerebral angiography.
At a glance
| Generic name | Visipaque - Hydrocortancyl |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | Non-ionic iso-osmolar contrast medium |
| Modality | Small molecule |
| Therapeutic area | Diagnostic Imaging |
| Phase | FDA-approved |
Mechanism of action
Visipaque contains iopamidol, an iodinated contrast agent that increases radiodensity in targeted anatomical regions, allowing for improved visualization during angiography and other radiographic procedures. The iso-osmolar formulation is designed to minimize osmotic stress on tissues and reduce nephrotoxicity compared to hyperosmolar contrast agents.
Approved indications
- Coronary angiography and ventriculography
- Peripheral vascular angiography
- Cerebral angiography
- Urography and other radiographic imaging procedures
Common side effects
- Contrast-induced nephropathy
- Allergic reactions (mild to severe)
- Nausea and vomiting
- Flushing and warmth sensation
- Hypersensitivity reactions
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Visipaque - Hydrocortancyl CI brief — competitive landscape report
- Visipaque - Hydrocortancyl updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI